Introduction: Patients with inflammatory bowel disease (IBD) report sexual problems and poor sexual health. This study aims to determine the prevalence of testicular hypogonadism (TH), or lowT, and erectile dysfunction (ED) in male patients with Crohn's disease (CD) or ulcerative colitis (UC). Methods: This is a retrospective review of male TRICARE beneficiaries with at least 1 gastrointestinal encounter during 2013-2015. Individuals with an ICD-9-CM code for CD (555.*), UC (556.*) and nonspecific colitis (558.*) were included. The outcomes were TH (ICD 9 code 257.2) and ED (ICD 9 codes 302.72) using patients with nonspecific colitis as controls. Demographic data on age at first IBD encounter (≥ 50 vs < 50 years), race and IBD-related medications were collected. Logistic regression analysis, accounting for age, was performed for each outcome. We cross-tabulated medication use by outcome among IBD patients. Results: We examined the records of 9347 patients: 228 CD patients, 387 UC patients and 8,732 controls. Of the 52.4% of individuals with race identified in their record, 78.5% were Caucasian, 17.4% were African American, and 3.6% were Asian. Median age was lower in controls compared with cases (26 vs 47 in CD and UC patients). After adjusting for age, patients with CD were significantly more likely to have TH than controls (1.2% controls, 4.8% CD patients, Odds Ratio (OR) 2.8; p = 0.003), but this relationship was not statistically significant in UC (2.8%, OR N; p = 0.215). After adjusting for age, patients with UC were more likely to have ED than controls (3.2% controls, 12.1% UC patients, OR 2.0; p < 0.001), but the relationship with CD was not statistically significant (9.2%, OR 1.5; p = 0.096). More IBD patients (5.3% CD, 3.9% UC) were prescribed testosterone than controls (1.4%, p < 0.001). Those with TH and ED were more likely to use testosterone than those without the conditions. CD patients with TH were more likely to be prescribed biologics than those without TH (63.6% vs 15.7%, p < 0.001). There were no other differences in TH or ED by IBD-related medications. Conclusion: Patients with IBD are more likely to have or seek out care for sexual health concerns than controls. While such health concerns are likely underreported in both controls and IBD patients, addressing them as a part of routine health care maintenance in IBD patients may improve quality of life.